| 000 | 01642 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250515140118.0 | ||
| 264 | 0 | _c20090109 | |
| 008 | 200901s 0 0 eng d | ||
| 022 | _a1460-2091 | ||
| 024 | 7 |
_a10.1093/jac/dkn402 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMowat, Eilidh | |
| 245 | 0 | 0 |
_aPhase-dependent antifungal activity against Aspergillus fumigatus developing multicellular filamentous biofilms. _h[electronic resource] |
| 260 |
_bThe Journal of antimicrobial chemotherapy _cDec 2008 |
||
| 300 |
_a1281-4 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAmphotericin B _xpharmacology |
| 650 | 0 | 4 |
_aAntifungal Agents _xpharmacology |
| 650 | 0 | 4 |
_aAspergillus fumigatus _xdrug effects |
| 650 | 0 | 4 |
_aBiofilms _xdrug effects |
| 650 | 0 | 4 | _aCaspofungin |
| 650 | 0 | 4 |
_aEchinocandins _xpharmacology |
| 650 | 0 | 4 |
_aFormazans _xmetabolism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLipopeptides |
| 650 | 0 | 4 |
_aMicrobial Sensitivity Tests _xmethods |
| 650 | 0 | 4 | _aMicrobial Viability |
| 650 | 0 | 4 |
_aMycelium _xdrug effects |
| 650 | 0 | 4 | _aOxidation-Reduction |
| 650 | 0 | 4 |
_aPyrimidines _xpharmacology |
| 650 | 0 | 4 |
_aSpores, Fungal _xdrug effects |
| 650 | 0 | 4 |
_aTriazoles _xpharmacology |
| 650 | 0 | 4 | _aVoriconazole |
| 700 | 1 | _aLang, Sue | |
| 700 | 1 | _aWilliams, Craig | |
| 700 | 1 | _aMcCulloch, Elaine | |
| 700 | 1 | _aJones, Brian | |
| 700 | 1 | _aRamage, Gordon | |
| 773 | 0 |
_tThe Journal of antimicrobial chemotherapy _gvol. 62 _gno. 6 _gp. 1281-4 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/jac/dkn402 _zAvailable from publisher's website |
| 999 |
_c18286974 _d18286974 |
||